PDS Biotechnology Corporation

PDS Biotechnology Corporationverified

PDSB

Price:

$2.7599

Market Cap:

$101.23M

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related prot...[Read more]

Industry

Biotechnology

IPO Date

2015-09-30

Stock Exchange

NASDAQ

Ticker

PDSB

The Current Ratio as of June 2024 (TTM) for PDS Biotechnology Corporation (PDSB) is 4.56

According to PDS Biotechnology Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.56. This represents a change of -21.10% compared to the average of 5.78 of the last 4 quarters.

PDS Biotechnology Corporation (PDSB) Historical Current Ratio (quarterly & annually)

How has PDSB Current Ratio performed in the past?

The mean historical Current Ratio of PDS Biotechnology Corporation over the last ten years is 9.22. The current 4.56 Current Ratio has changed 4.85% with respect to the historical average. Over the past ten years (40 quarters), PDSB's Current Ratio was at its highest in in the September 2016 quarter at 26.60. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

9.22

Median

7.35

Minimum

3.97

Maximum

17.80

PDS Biotechnology Corporation (PDSB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PDS Biotechnology Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 285.29%

Maximum Annual Current Ratio = 17.80

Minimum Annual Increase = -56.90%

Minimum Annual Current Ratio = 3.97

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.33-44.36%
20227.79-56.24%
202117.8091.84%
20209.2879.08%
20195.18-7.28%
20185.59-19.29%
20176.92-56.90%
201616.065.09%
201515.28285.29%
20143.97-16.85%

PDS Biotechnology Corporation (PDSB) Average Current Ratio

How has PDSB Current Ratio performed in the past?

The current Current Ratio of PDS Biotechnology Corporation (PDSB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.97

5-year avg

8.87

10-year avg

9.22

PDS Biotechnology Corporation (PDSB) Current Ratio vs. Peers

How is PDSB’s Current Ratio compared to its peers?

PDS Biotechnology Corporation’s Current Ratio is less than Mereo BioPharma Group plc (0), less than Terns Pharmaceuticals, Inc. (4.86), less than Inozyme Pharma, Inc. (27.85), less than HOOKIPA Pharma Inc. (14.05), greater than eFFECTOR Therapeutics, Inc. (4.50), greater than Enveric Biosciences, Inc. (1.03), greater than CohBar, Inc. (3.48), greater than Ocean Biomedical, Inc. (4.16), greater than AVROBIO, Inc. (0.03), less than X4 Pharmaceuticals, Inc. (26.17), greater than Day One Biopharmaceuticals, Inc. (3.71), less than Elevation Oncology, Inc. (10.93), less than null (46.22),

Build a custom stock screener for PDS Biotechnology Corporation (PDSB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PDS Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PDS Biotechnology Corporation (PDSB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PDS Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is PDS Biotechnology Corporation's Current Ratio?

How is the Current Ratio calculated for PDS Biotechnology Corporation (PDSB)?

What is the highest Current Ratio for PDS Biotechnology Corporation (PDSB)?

What is the 3-year average Current Ratio for PDS Biotechnology Corporation (PDSB)?

What is the 5-year average Current Ratio for PDS Biotechnology Corporation (PDSB)?

How does the current Current Ratio for PDS Biotechnology Corporation (PDSB) compare to its historical average?